Navigation Links
AMETEK Acquires Technical Services for Electronics

PAOLI, Pa., June 1 /PRNewswire-FirstCall/ -- AMETEK, Inc. (NYSE: AME) today announced that it has acquired Technical Services for Electronics (TSE), a privately held manufacturer of engineered interconnect solutions for the medical device industry. TSE is headquartered in Arlington, MN and has manufacturing operations in Jackson, MN; Beaverton, OR; and Taipei, Taiwan. It has expected annual sales of $50 million. AMETEK purchased TSE from Pfingsten Partners, LLC, an operationally focused private equity firm based in Chicago, IL.

"TSE greatly expands our position in the highly attractive medical device market and is an excellent fit with our HCC Division, which manufactures highly engineered electronic interconnects and microelectronic packages for sophisticated electronic applications," comments Frank S. Hermance, AMETEK Chairman and Chief Executive Officer.

"TSE enjoys an excellent reputation with leading medical device OEMs. Its products, which include customized multi-lead and fine wire interconnects, cable assemblies, leads, and antennas, serve a number of high-growth therapeutic sectors, including neuro-stimulation, patient monitoring, ultrasound, cardiac rhythm management and cardiac mapping," adds Mr. Hermance.

TSE joins AMETEK as part of its Electromechanical Group (EMG)--a differentiated supplier of electrical interconnects, specialty metals, technical motors, floor care motors and specialty motors with 2009 sales of $952 million.

Corporate Profile

AMETEK is a leading global manufacturer of electronic instruments and electro-mechanical devices with 2009 sales of $2.1 billion. AMETEK's Corporate Growth Plan is based on Four Key Strategies: Operational Excellence, Strategic Acquisitions & Alliances, Global & Market Expansion and New Products. AMETEK's objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital. The common stock of AMETEK is a component of the S&P MidCap 400 and the Russell 1000 Indices.

Forward-looking Information

Statements in this news release relating to future events, such as AMETEK's expected business and financial performance are "forward-looking statements."  Forward-looking statements are subject to various factors and uncertainties that may cause actual results to differ significantly from expectations.  These factors and uncertainties include our ability to consummate and successfully integrate future acquisitions; risks associated with international sales and operations; our ability to successfully develop new products, open new facilities or transfer product lines; the price and availability of raw materials; compliance with government regulations, including environmental regulations; changes in the competitive environment or the effects of competition in our markets; the ability to maintain adequate liquidity and financing sources; and general economic conditions affecting the industries we serve.  A detailed discussion of these and other factors that may affect our future results is contained in AMETEK's filings with the U.S. Securities and Exchange Commission, including its most recent reports on Form 10-K, 10-Q and 8-K.  AMETEK disclaims any intention or obligation to update or revise any forward-looking statements.

Contact:  William Burke (610) 889-5249

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China BCT Acquires 11 Stores, Expanding Retail Pharmacy Network
2. US HIFU Acquires European Distribution Rights of the Sonablate® 500 Medical Device and Ownership of the Sonatherm® 600 Medical Device
3. Inteplast Acquires Medical Packaging Division
4. Perrigo Acquires Rights to Generic Version of HalfLytely® from Novel Laboratories
5. Hanley Center Acquires the East Coasts First SPECT Scanner to Treat Addiction
6. Health Robotics Re-Acquires CytoCares European Rights from B. Braun Melsungen AG for Undisclosed Consideration
7. Ferring Acquires LYSTEDA(TM) From Xanodyne Pharmaceuticals, Inc.
8. Waste Management Acquires Certain Assets of MedServe From Stericycle
9. Intercell Acquires Antibody Technology Platform to Further Exploit Its Capabilities to Combat Infectious Diseases
10. Althea Technologies Acquires Altus Pharmaceuticals(R) Assets and IP Portfolio, Establishing Technology Platform for Protein Formulations.
11. Mesa Labs Acquires SGM Biotech, Inc.
Post Your Comments:
(Date:11/27/2015)... 2015 Research and Markets ( ) ... Devices Market 2015-2019" report to their offering. ... this report, the author the present scenario and growth ... To calculate the market size, the report considers revenue ... Hormonal IUDs and copper IUDs. The report forecasts the ...
(Date:11/26/2015)... November 27, 2015 ... --> Medical alert ... system (PERS) market is expected ... years with APAC being the ... see a high CAGR between ...
(Date:11/26/2015)... North Carolina , 26 november 2015 ... Inc. (AAIPharma/CML) kondigt de geplande investering aan ... uitbreiding van de laboratoria en het mondiale ... . De uitbreiding zal resulteren in extra ... wordt voldaan aan de groeiende behoeften van ...
Breaking Medicine Technology:
(Date:11/27/2015)... Chicago, IL (PRWEB) , ... November 27, 2015 ... ... some of the largest, most successful and prominent nonprofit healthcare organizations in the ... and governance involvement with various organizations, and helped advance the healthcare industry as ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... Avid collector, ... Ann Arbor Michigan boxing style concert posters. This is one of Joplin's most famous ... Canterbury House at the University of Michigan in Ann Arbor. The According to Hawley, ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... located in central Michigan, have come together on Thanksgiving Day to share the ... available for viewing on the Serenity Point YouTube channel, patients displayed what they ...
(Date:11/26/2015)... ... November 26, 2015 , ... CognisantMD ... for diagnostic imaging in the Waterloo region. Using the Ocean Platform, family physicians ... directly from their electronic medical record (EMR) without the need for redundant patient ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied Drug ... need to integrate dose form selection in early phase drug development. The first ... supporting and bringing together the UK’s emerging life sciences companies, corporate partners, and ...
Breaking Medicine News(10 mins):